RE:RE:RE:RE:I want to be a cheerleader for this company but…Good post BlueJay, you made me go to the way back machine to see if we can learn anything from the run up in 2016. Spectral 2016:
Jan 11 Announce 400 of 446 were enrolled (90%) SharePrice .79
Jan 12 A very favorable $2.50 target analysis by Mackie Research Capital Corp. (who coincidently also underwrote Spectral financing (with Cormark)) SP .80
Feb 24 Raise closes for 7.1M (US) to finalize trial. SP .80
June 16 Spectral touts PMA acceptance. SP .88
Jun 20th Announces completion of enrollment. SP .88
June 27 Wins compassionate use exemption from FDA. SP .95
July 4 Spectral announces plans to buy back up to 4.1 million shares. SP $1.01 (continues to move up to $1.21 in July)
Sept 27 Closes at $1.86 the week before numbers released.
Oct 3rd Top line numbers released...
If I'm missing anything please add. I know Dr Walker made his positive trial prediction in Sept. but I couldn't track down the date.
My takeaway is the price just creeped up with positive news/ enrollment. The first real movement came with the announcing the 4.1M share buy back. That "action" was a very loud "exceeding expectations!!". (In reality I can't see that they acutaly bought shares back- but it got the ball moving).
The largest jump was in the last 2 weeks before the numbers were to be released $1.13- 1.86. The power of old school, late money, fomo...